Cigna (CI) Stock Forecast & Price Target

Compare

3,573 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CI Analyst Ratings

Strong Buy

13 Buy

2 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$338.69

▲(18.95% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $338.69 with a high forecast of $378.00 and a low forecast of $300.00. The average price target represents a 18.95% change from the last price of $284.74.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"242":"$242","379":"$379","276.25":"$276.3","310.5":"$310.5","344.75":"$344.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":378,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$378.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":338.69,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$338.69</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$300.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[242,276.25,310.5,344.75,379],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,290.85,297.55384615384617,304.2576923076923,310.96153846153845,317.66538461538465,324.3692307692308,331.07307692307694,337.7769230769231,344.4807692307692,351.18461538461537,357.88846153846157,364.5923076923077,371.29615384615386,{"y":378,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,290.85,294.53000000000003,298.21000000000004,301.89000000000004,305.57,309.25,312.93,316.61,320.29,323.97,327.65,331.33,335.01,{"y":338.69,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,290.85,291.55384615384617,292.2576923076923,292.96153846153845,293.66538461538465,294.3692307692308,295.07307692307694,295.7769230769231,296.4807692307692,297.18461538461537,297.88846153846157,298.5923076923077,299.29615384615386,{"y":300,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":302.629,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":325.927,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.042,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.162,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.851,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.454,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.685,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.044,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":272.041,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.23,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.54,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.85,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$378.00

Average Price Target$338.69

Lowest Price Target$300.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Baxter

Wells Fargo

$300

Hold

5.36%

Upside

Reiterated

03/04/26

Wall Street Analysts Are Neutral on Top Healthcare Picks

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

03/03/26

JPMorgan didn't expect Cigna CEO change, says in 'capable hands'JPMorgan didn't expect Cigna CEO change, says in 'capable hands'

Scott Fidel

Goldman Sachs

$335

Buy

17.65%

Upside

Reiterated

03/03/26

Cigna: Leadership Transition, Reaffirmed 2026 Targets, and Attractive Valuation Support Buy Rating

Andrew Mok CFA

Barclays

$303

Buy

6.41%

Upside

Reiterated

03/03/26

Cigna CEO change timing 'may surprise some investors,' says BarclaysCigna CEO change timing 'may surprise some investors,' says Barclays

Jessica Tassan

Piper Sandler

$374→$370

Buy

29.94%

Upside

Reiterated

03/03/26

Cigna price target lowered to $370 from $374 at Piper SandlerCigna price target lowered to $370 from $374 at Piper Sandler

Erin Wright

Morgan Stanley

$355

Buy

24.68%

Upside

Reiterated

02/24/26

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (NASDAQ: PVLA), Larimar Therapeutics (NASDAQ: LRMR) and Cigna (NYSE: CI)

George Hill

Deutsche Bank

―

Buy

―

Reiterated

02/20/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

David S Macdonald

Truist Financial

$320→$350

Buy

22.92%

Upside

Reiterated

02/17/26

Truist Financial Sticks to Their Buy Rating for Cigna (CI)

Kevin Caliendo

UBS

$340→$375

Buy

31.70%

Upside

Reiterated

02/09/26

Cigna price target raised to $375 from $340 at UBSCigna price target raised to $375 from $340 at UBS

Charles Rhyee

TD Cowen

$333→$338

Buy

18.70%

Upside

Reiterated

02/09/26

Cigna: Regulatory Overhang Eases, Evernorth Growth Drives Renewed Buy Rating and Earnings Upside

Kevin Fischbeck

Bank of America Securities

$378

Buy

32.75%

Upside

Reiterated

02/06/26

Analysts Conflicted on These Healthcare Names: Cigna (NYSE: CI), Hims & Hers Health (NYSE: HIMS) and Omnicell (NASDAQ: OMCL)

Ben Hendrix

RBC Capital

$344→$333

Buy

16.95%

Upside

Reiterated

02/05/26

RBC Capital Sticks to Their Buy Rating for Cigna (CI)

Jason Cassorla

Guggenheim

$318→$334

Buy

17.30%

Upside

Reiterated

02/05/26

Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Envista Holdings (NVST)

Lance Wilkes

Bernstein

$307

Hold

7.82%

Upside

Reiterated

01/27/26

Bernstein Sticks to Their Hold Rating for Cigna (CI)

Ann Hynes

Mizuho Securities

$307→$325

Buy

14.14%

Upside

Reiterated

01/09/26

Cigna price target raised to $325 from $307 at MizuhoCigna price target raised to $325 from $307 at Mizuho

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Baxter

Wells Fargo

$300

Hold

5.36%

Upside

Reiterated

03/04/26

Wall Street Analysts Are Neutral on Top Healthcare Picks

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

03/03/26

JPMorgan didn't expect Cigna CEO change, says in 'capable hands'JPMorgan didn't expect Cigna CEO change, says in 'capable hands'

Scott Fidel

Goldman Sachs

$335

Buy

17.65%

Upside

Reiterated

03/03/26

Cigna: Leadership Transition, Reaffirmed 2026 Targets, and Attractive Valuation Support Buy Rating

Andrew Mok CFA

Barclays

$303

Buy

6.41%

Upside

Reiterated

03/03/26

Cigna CEO change timing 'may surprise some investors,' says BarclaysCigna CEO change timing 'may surprise some investors,' says Barclays

Jessica Tassan

Piper Sandler

$374→$370

Buy

29.94%

Upside

Reiterated

03/03/26

Cigna price target lowered to $370 from $374 at Piper SandlerCigna price target lowered to $370 from $374 at Piper Sandler

Erin Wright

Morgan Stanley

$355

Buy

24.68%

Upside

Reiterated

02/24/26

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (NASDAQ: PVLA), Larimar Therapeutics (NASDAQ: LRMR) and Cigna (NYSE: CI)

George Hill

Deutsche Bank

―

Buy

―

Reiterated

02/20/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

David S Macdonald

Truist Financial

$320→$350

Buy

22.92%

Upside

Reiterated

02/17/26

Truist Financial Sticks to Their Buy Rating for Cigna (CI)

Kevin Caliendo

UBS

$340→$375

Buy

31.70%

Upside

Reiterated

02/09/26

Cigna price target raised to $375 from $340 at UBSCigna price target raised to $375 from $340 at UBS

Charles Rhyee

TD Cowen

$333→$338

Buy

18.70%

Upside

Reiterated

02/09/26

Cigna: Regulatory Overhang Eases, Evernorth Growth Drives Renewed Buy Rating and Earnings Upside

Kevin Fischbeck

Bank of America Securities

$378

Buy

32.75%

Upside

Reiterated

02/06/26

Analysts Conflicted on These Healthcare Names: Cigna (NYSE: CI), Hims & Hers Health (NYSE: HIMS) and Omnicell (NASDAQ: OMCL)

Ben Hendrix

RBC Capital

$344→$333

Buy

16.95%

Upside

Reiterated

02/05/26

RBC Capital Sticks to Their Buy Rating for Cigna (CI)

Jason Cassorla

Guggenheim

$318→$334

Buy

17.30%

Upside

Reiterated

02/05/26

Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Envista Holdings (NVST)

Lance Wilkes

Bernstein

$307

Hold

7.82%

Upside

Reiterated

01/27/26

Bernstein Sticks to Their Hold Rating for Cigna (CI)

Ann Hynes

Mizuho Securities

$307→$325

Buy

14.14%

Upside

Reiterated

01/09/26

Cigna price target raised to $325 from $307 at MizuhoCigna price target raised to $325 from $307 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months

xxx

Success Rate

20/30 ratings generated profit

Average Return

+4.67%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.67% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

21/28 ratings generated profit

Average Return

+18.45%

reiterated a buy rating 4 months ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +18.45% per trade.

2 Years

xxx

Success Rate

18/19 ratings generated profit

Average Return

+25.17%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +25.17% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CI has received 53 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 338.69.

Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $7.61 with a range of $6.64 to $7.92. The previous quarter’s EPS was $8.08. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $66.89B with a range of $64.63B to $70.60B. The previous quarter’s sales results were $72.37B. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 338.69.

What is CI’s upside potential, based on the analysts’ average price target?

Cigna Corp has 18.95% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CI a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.

What is Cigna Corp’s price target?

The average price target for Cigna Corp is 338.69. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $378.00 ,the lowest forecast is $300.00. The average price target represents 18.95% Increase from the current price of $284.74.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of CI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cigna (CI) Stock Forecast & Price Target

CI Analyst Ratings

CI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CI Analyst Recommendation Trends

CI Financial Forecast

CI Earnings Forecast

CI Sales Forecast

CI Stock Forecast FAQ

Detailed List of Analyst Forecasts